Article ID Journal Published Year Pages File Type
23733 Journal of Biotechnology 2011 9 Pages PDF
Abstract

The production of monoclonal antibodies by hybridoma technology is dependent on lymphocytes taken from vertebrates which have to be immunized against the corresponding antigen. We present here our first experiments which should allow the replacement of this in vivo immunization step by an in vitro immunization procedure. This work provides new possibilities for the specific activation of immune cells in order to use them for the generation of antibodies which are not of murine origin. Bone marrow-derived dendritic cells were loaded with antigen and co-cultured with naïve T and B lymphocytes of non-immunized mice. The interaction and activation of the different cell types were investigated by measuring the expression of specific cell surface markers, the release of activation-dependent interleukins and the secretion of antigen-specific antibodies. We could demonstrate that dendritic cells process and present antigen fragments and activate T cells, that T cells proliferate and release activation-induced interleukins, and that B cells maturate under the influence of activated T cells and secrete antigen-specific antibodies.

► Cocultivation of naïve immune cells to induce antigen-specific activation. ► Detection of OVA-specific antibodies in vitro. ► Antigen uptake, activation marker and cytokine profiles were investigated.

Related Topics
Physical Sciences and Engineering Chemical Engineering Bioengineering
Authors
, , , , ,